Medication info
Esomeprazole Magnesium Hydrate 40 mg Tablets

Esomeprazole Magnesium Hydrate 40 mg Tablets

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Trihydrate›44.5mg / 1 tablet
Manufacturer / importer
OS Korea Pharmaceutical Co., Ltd.
Appearance
Pink, round, film-coated tablet
Packaging
28 tablets/box [14 tablets/Alu-Alu×2]
Approval status
Active

MFDS item code 202000182 · Approved 2020.01.13

Summary

Main use
Treatment of reflux and Zollinger-Ellison syndrome; eradication therapy; treatment of gastrointestinal symptoms and ulcers, and prevention of rebleeding
Who uses it
Adults · Children
Adult dosage
1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg per dose once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for another 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg per dose once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg per dose once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have improved, control subsequent symptoms by administering 20 mg per dose once daily. · In adults, 20 mg per dose may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with nonsteroidal anti-inflammatory drug (nonselective or selective COX-2) use - 20 mg per dose once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials lasting more than 4 weeks have not been conducted. 4) Patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg per dose once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg per dose once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided into 2 doses. 6) Maintenance therapy following intravenous induction of prevention of rebleeding from gastric or duodenal ulcers Administer 40 mg per dose once daily for 4 weeks following intravenous induction of prevention of rebleeding from gastric or duodenal ulcers. 5. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. 6. Older adults: No dose adjustment is necessary.
Children's dosage
2. Adolescents 12 years of age and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. · Once symptoms have resolved, subsequent recurrent symptoms may be controlled with 20 mg once daily. 3. Children under 12 years of age: There is no experience with administration of this medicine to children under 12 years of age.

Ingredients

Manufacturer
OS Korea Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of reflux and Zollinger-Ellison syndrome; eradication therapy; treatment of gastrointestinal symptoms and ulcers, and prevention of rebleeding

  • Erosive gastroesophageal reflux disease
  • esophagitis
  • symptoms of gastroesophageal reflux disease
  • duodenal ulcer
  • peptic ulcer
  • upper gastrointestinal pain
  • discomfort in the upper gastrointestinal tract
  • burning sensation in the upper gastrointestinal tract
  • gastric ulcer
  • duodenal ulcer
  • Zollinger-Ellison syndrome
  • rebleeding of gastric ulcer
View approved original text

This medication is used to treat gastroesophageal reflux disease and erosive esophagitis, and it also aids in long-term maintenance therapy to prevent relapse in patients with esophagitis. In addition, it is effective for the treatment and prevention of recurrence in patients with duodenal ulcers and peptic ulcers, included as part of antibiotic combination therapy to eradicate Helicobacter pylori. It is also used for the short-term treatment of upper gastrointestinal symptoms caused by the use of non-steroidal anti-inflammatory drugs and for the treatment and prevention of gastric and duodenal ulcers. Furthermore, it is used in the treatment of Zollinger-Ellison syndrome and as maintenance therapy to prevent bleeding from gastric or duodenal ulcers, improving symptoms in patients. Thus, it is effective for the treatment and prevention of various gastrointestinal diseases, significantly aiding in the improvement of patients' health.

Dosage and Administration

Adult dosage

1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg per dose once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for another 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg per dose once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg per dose once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have improved, control subsequent symptoms by administering 20 mg per dose once daily. · In adults, 20 mg per dose may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with nonsteroidal anti-inflammatory drug (nonselective or selective COX-2) use - 20 mg per dose once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials lasting more than 4 weeks have not been conducted. 4) Patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg per dose once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg per dose once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided into 2 doses. 6) Maintenance therapy following intravenous induction of prevention of rebleeding from gastric or duodenal ulcers Administer 40 mg per dose once daily for 4 weeks following intravenous induction of prevention of rebleeding from gastric or duodenal ulcers. 5. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. 6. Older adults: No dose adjustment is necessary.

Children's dosage

2. Adolescents 12 years of age and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. · Once symptoms have resolved, subsequent recurrent symptoms may be controlled with 20 mg once daily. 3. Children under 12 years of age: There is no experience with administration of this medicine to children under 12 years of age.

Precautions

This medication should not be used in certain patients. For example, patients who are allergic to this drug, its components, or have experienced hypersensitivity reactions should not take it. Additionally, patients with allergies to penicillin or macrolide antibiotics should be cautious when taking this medication in combination. Patients who are taking certain drugs, such as terfenadine, cisapride, pimodivir, astemizole, atazanavir, nelpivirine, or rilpivirine should also avoid taking this medication due to potential issues. Women who are breastfeeding and patients with a history of myocardial infarction should not take this medication. This drug can cause various adverse reactions such as headaches, abdominal pain, diarrhea, nausea, vomiting, skin rashes, muscle pain, and low magnesium levels. In severe cases, rare occurrences of anaphylactic shock, liver failure, and serious skin reactions may occur, so it is important to consult a doctor immediately if symptoms worsen or if adverse reactions are suspected. Regular examinations are crucial to check for adverse reactions during long-term use. Special caution is needed for long-term use exceeding one year due to the risk of fractures and the possibility of low magnesium levels. This drug suppresses gastric acid secretion, which can promote bacterial growth in the stomach, potentially increasing the risk of infections such as diarrhea. This medication has a high potential for drug interactions, especially when taken with anticoagulants, antiviral medications, antibiotics, or anticonvulsants, and adjustments should be made in consultation with a doctor or pharmacist. Safety data regarding use during pregnancy is limited, therefore pregnant women should consult healthcare professionals before taking this medication, and it is advisable for breastfeeding women not to take it. In the event of an overdose, there are no specific antidotes, so appropriate treatment should be received based on symptoms. Safe storage is necessary, keeping it out of the reach of children.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucination, headache, dizziness, altered perception, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel syndrome, acute generalized pustular psoriasis, eosinophilia, drug reactions with systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, lethargy, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, worsened constipation, dyspepsia, dysphagia, gastrointestinal malformation, upper abdominal pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, vomiting, otalgia, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, abnormal liver function, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, arthralgia, loss of appetite, apathy, increased appetite, confusion, exacerbation of depression, hypertonia, anxiety, sensory impairment, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, dizziness, visual field defect, altered perception, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, bullous rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, abnormal olfaction, taste loss, taste distortion, urine abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, discoid lupus erythematosus, gastric fundic gland polyp, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air or moisture. It is best to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Pink, round, film-coated tablet

Package unit

28 tablets/box [14 tablets/Alu-Alu×2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.